The Next Theranos? An Alzheimer’s Drug and a CUNY Professor Face Questions Over Research Validity
Cassava Sciences touted the drug simuphilam as a cure to Alzheimer’s Disease. Now, the core science behind the drug that was partially pioneered by a CUNY professor is being questioned by scientists and regulators alike. The scientific journal PLoS One retracted five studies co-authored by Dr. Hoau-Yan Wang, an associate medical professor at the…

